India’s Jubilant, Belgium’s Janssen To Ally For Neuroscience Drugs
This article was originally published in PharmAsia News
Executive Summary
The U.S. unit of India's Jubilant Life Sciences and Johnson & Johnson company Janssen Pharmaceutica have agreed to an alliance in neuroscience efforts